Loading…
METHOCARBAMOL is a brand name for Methocarbamol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: As a short-term adjunct to the symptomatic treatment of acute musculoskeletal disorders associated with painful muscle spasms, especially in the area of the back (lumbago). Methocarbamol 750mg film-coated tablets is indicated in adults.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults:
The usual dose is 2 tablets (1500 mg methocarbamol) three times a day. At the beginning of treatment, a dosage of 2 tablets (1500 mg methocarbamol) four times a day recommended. In severe cases, patients may take 2 tablets (1500 mg methocarbamol) five times (7500 mg methocarbamol) per day.
Elderly:
Half the maximum dose or less may be sufficient to produce a therapeutic response. Paediatric population The safety and efficacy of Methocarbamol 750mg film-coated tablets in children and adolescents have not been established.
Hepatically impaired:
In patients with chronic hepatic disease the elimination half-life may be prolonged. Therefore, consideration should be given to increasing the dose interval.
Duration of Treatment:
The duration of administration depends on the symptoms induced by increased muscle tone, but should not exceed 30 days. Method of administration For oral use. The coated tablets are swallowed with a large amount of water.
g. g. lips, tongue) or extremities (hand, fingers, feet). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellocard or by searching for MHRA Yellow Card in the Google Play or Apple App Store.
Methocarbamol should be used with caution in patients with impaired renal and/or hepatic function. This medicine contains Lactose Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
1. Coma or pre-coma states. Central nervous system (CNS) disease. Known brain damage or epilepsy. Myasthenia gravis.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Methocarbamol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.